Q4 2020 Holdings
Filed 2021-02-16 | 30 holdings | $5.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moderna Inc(MRNA) | COM | 60770K107 | $3.2M | 30,871,524 | 58.7% |
| Sigilon Therapeutics Inc | COM | 82657L107 | $498.1K | 10,370,369 | 9.1% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $359.5K | 14,673,973 | 6.5% |
| Rubius Therapeutics Inc | COM | 78116T103 | $290.7K | 38,296,526 | 5.3% |
| Evelo Biosciences Inc | COM | 299734103 | $276.9K | 22,900,069 | 5.0% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $256.9K | 12,674,120 | 4.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $228.7K | 2,730,263 | 4.2% |
| Kaleido Biosciences Inc(KLDO) | COM | 483347100 | $176.2K | 19,360,710 | 3.2% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $84.2K | 2,607,303 | 1.5% |
| Axcella Health Inc | COM | 05454B105 | $65.1K | 12,548,414 | 1.2% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $31.9K | 2,938,494 | 0.6% |